During the past decade, Siouxland Hematology Oncology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 6 clinical trials were completed, i.e. on average, 600% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Siouxland Hematology Oncology" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 69 trials, followed by "SWOG Cancer Research Network" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "National Cancer Institute (NCI)" with 3 trials sponsored and "Eastern Cooperative Oncology Group" with 3 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Siouxland Hematology Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 79 trials as a collaborator, "North Central Cancer Treatment Group" with 12 trials as a collaborator, "Eastern Cooperative Oncology Group" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "Cancer and Leukemia Group B" with 3 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Siouxland Hematology Oncology" are "Breast Cancer" (20 trials), "Lung Cancer" (15 trials), "Colorectal Cancer" (12 trials), "Lymphoma" (9 trials) and "Prostate Cancer" (6 trials). Many other conditions were trialed in "Siouxland Hematology Oncology" in a lesser frequency.

Most popular intervention types in "Siouxland Hematology Oncology" are "Drug" (77 trials), "Other" (15 trials), "Radiation" (15 trials), "Biological" (11 trials) and "Dietary Supplement" (8 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (14 trials), "gemcitabine hydrochloride" (12 trials), "radiation therapy" (11 trials), "fluorouracil" (10 trials) and "paclitaxel" (10 trials). Other intervention names were less common.

The vast majority of trials in "Siouxland Hematology Oncology" are 73 trials for "All" genders, 13 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Siouxland Hematology Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 89 completed trials in Siouxland Hematology Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Siouxland Hematology Oncology, 3 "Phase 1" clinical trials were conducted, 51 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".